REX American Resources (REX) Fundamental Analysis: Bull vs. Bear Case

REX

REX American Resources

Fundamental data last updated:April 13, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Basic Materials

industry

Chemicals

Exchange

NYSE

County of HQ

United States

Next Earnings Date

05/27/26

Business Summary

REX American Resources generates cash through chemical and energy-related production assets that convert commodity inputs into higher-value outputs, monetizing processing spreads rather than relying on branded pricing power. The business model is capital intensive but disciplined, as evidenced by double-digit ROIC and strong operating margins. Its moat is balance-sheet strength and operational efficiency — low leverage and high liquidity allow it to endure commodity cycles that would strain weaker peers. Cash generation hinges on maintaining spread discipline, cost control, and prudent capital allocation rather than on structural pricing power.

VALUATION

P/E

17.7 Market Cap ($M USD)

$1,456

Forward P/E

14.7 PEG

0.5 PRICE TO SALES

2.3 PRICE TO BOOK

2.4 EV / EBITDA

13.1 5-Year Average P/E

Free Cash Flow Yield

DCF Value

Graham Number

Price to FCF

EV to FCF

Earnings Yield

FCF Yield

DIVIDEND

Yield

-

Annual Payout

-

Payout Ratio

-

Consecutive Years of Dividend Growth

0 5-Year Dividend Growth Rate

-

Financial Health & Profitability

Earnings Per Share

$2.50

Next Year EPS Growth Estimate

$3.00

Next Year Revenue Growth Estimate

20.50%

Return on Equity (ROE)

13.60%

FREE CASH FLOW

Operating Margin

9.40%

Debt-to-Equity

0 Piotroski F-Score

7 Altman Z-Score

11.8 Return on Invested Capital (ROIC)

12.20%

Current Ratio

5.9 Quick Ratio

Net Debt to EBITDA

Interest Coverage

Gross Profit margin

FCF PER SHARE

REVENUE PER SHARE

Gainseekers Quantitative Analysis

Summary

At 17.7x earnings and 14.7x forward earnings, REX is not statistically cheap, but the 0.5 forward PEG suggests the market is pricing in muted or uneven growth despite valuation compression. The balance sheet is fortress‑like with an Altman Z-Score of 11.8, Debt/Equity of just 9.40%, and a Current Ratio of 5.9, signaling virtually no financial distress risk. ROE of 20.50% and ROIC of 12.20% indicate real capital efficiency, yet the dramatic shift from EPS of 13.1 to an estimated $2.50 next year implies earnings normalization that could justify caution. This is not a distressed mispricing; it is a cyclical name priced at a moderate multiple with exceptional financial safety but visible earnings volatility ahead.

AI Exposure / Tech Reliance

As a Chemicals company within Basic Materials, REX operates in a capital‑intensive, process‑driven industry where AI integration typically enhances efficiency rather than transforms demand. Margin optimization, predictive maintenance, and yield management can support its 13.60% operating margin over time. However, the sector is not inherently high‑growth from AI disruption, so tech resilience is operational rather than revenue‑expansive.

The Bull Case

A GARP or deep value investor will focus on the internal quality metrics: ROE at 20.50% and ROIC at 12.20% show the company generates returns comfortably above capital costs, while a Piotroski F-Score of 7 signals strong balance sheet and operating momentum. Operating margins of 13.60% in a commodity-linked industry demonstrate disciplined cost control. The 0.5 forward PEG is the statistical hook — growth is being priced cheaply relative to the forward multiple of 14.7. Add in minimal leverage (9.40% Debt/Equity) and extreme solvency strength (11.8 Altman Z-Score), and you have a financially hardened company capable of weathering cyclical troughs without dilution or distress.

The Bear Case

The glaring issue is earnings compression: EPS of 13.1 versus estimated EPS next year of $2.50 is not a mild slowdown — it is a collapse. Despite a PEG of 0.5, the forward earnings base is materially lower, and “Sales Growth Next Year: $3.00” lacks clarity in scale, making growth visibility questionable. With no dividend, zero TTM yield, and no payout support, shareholders rely entirely on earnings stability that currently appears volatile. Consensus Rating of 3.40% and a Mean Consensus Target Price of 1 offer little actionable conviction, while the absence of Short % data reduces transparency around bearish positioning.

Market Sentiment & Smart Money

Short Interest %

3.40%

Analyst Consensus

1 Average Analyst Price Target

$50.00

Institutional Ownership %

83.10%

1-Year Beta

0.37 Insider Buying % (6 Mo)

15.40%%

Distance to 52-Week High

90.90%

Distance to 52-Week Low

237.10%

EARNINGS SURPRISE %

50-DAY SMA

200-DAY SMA

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.